- Home
- NMT vs ATRA Comparison
NMT vs ATRA Comparison
Compare NMT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMT
- ATRA
- Stock Information
- Founded
- NMT 1993
- ATRA 2012
- Country
- NMT United States
- ATRA United States
- Employees
- NMT N/A
- ATRA N/A
- Industry
- NMT Finance/Investors Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMT Finance
- ATRA Health Care
- Exchange
- NMT Nasdaq
- ATRA Nasdaq
- Market Cap
- NMT 108.0M
- ATRA 97.0M
- IPO Year
- NMT N/A
- ATRA 2014
- Fundamental
- Price
- NMT $11.56
- ATRA $14.41
- Analyst Decision
- NMT
- ATRA Strong Buy
- Analyst Count
- NMT 0
- ATRA 3
- Target Price
- NMT N/A
- ATRA $21.00
- AVG Volume (30 Days)
- NMT 19.1K
- ATRA 52.1K
- Earning Date
- NMT 01-01-0001
- ATRA 11-11-2025
- Dividend Yield
- NMT 3.21%
- ATRA N/A
- EPS Growth
- NMT N/A
- ATRA N/A
- EPS
- NMT N/A
- ATRA 0.56
- Revenue
- NMT N/A
- ATRA $188,667,000.00
- Revenue This Year
- NMT N/A
- ATRA N/A
- Revenue Next Year
- NMT N/A
- ATRA N/A
- P/E Ratio
- NMT N/A
- ATRA $25.58
- Revenue Growth
- NMT N/A
- ATRA 202.41
- 52 Week Low
- NMT $9.05
- ATRA $5.01
- 52 Week High
- NMT $10.93
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- NMT 50.73
- ATRA 68.37
- Support Level
- NMT $11.58
- ATRA $13.12
- Resistance Level
- NMT $11.72
- ATRA $14.78
- Average True Range (ATR)
- NMT 0.11
- ATRA 0.84
- MACD
- NMT -0.01
- ATRA 0.16
- Stochastic Oscillator
- NMT 17.94
- ATRA 86.14
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).